Penserra Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,785
| Closed | -$57K | – | 1479 |
|
|
2021
Q3 | $57K | Buy |
1,785
+30
| +2% | +$958 | ﹤0.01% | 1018 |
|
|
2021
Q2 | $53K | Buy |
1,755
+55
| +3% | +$1.66K | ﹤0.01% | 984 |
|
|
2021
Q1 | $51K | Sell |
1,700
-50
| -3% | -$1.5K | ﹤0.01% | 809 |
|
|
2020
Q4 | $34K | Buy |
1,750
+1,112
| +174% | +$21.6K | ﹤0.01% | 750 |
|
|
2020
Q3 | $8K | Buy |
+638
| New | +$8K | ﹤0.01% | 837 |
|